
pmid: 7802755
We describe a patient with marked elevations of creatine kinase following institution of clozapine treatment. The enzyme levels promptly subsided with discontinuation of clozapine. The clinical features did not meet any of the published criteria for neuroleptic malignant syndrome.
Adult, Male, Schizophrenia, Paranoid, Dose-Response Relationship, Drug, Humans, Neuroleptic Malignant Syndrome, Clozapine, Creatine Kinase, Drug Administration Schedule
Adult, Male, Schizophrenia, Paranoid, Dose-Response Relationship, Drug, Humans, Neuroleptic Malignant Syndrome, Clozapine, Creatine Kinase, Drug Administration Schedule
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 28 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
